Furthermore, through this approach, BCR::ABL1 kinase activity was barely detectable in CP-CML compared to Ph+ acute lymphoblastic leukemia primary samples, where kinase activity is comparable to those measured in Ph+ cell lines. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.